Vijaya Diagnostic Centre Limited
Aberdeen sold 1,33,199 shares of Vijaya Diagnostic Centre Limited through an open-market sale, reducing its stake from 3.37% to 3.24%.
A leading diagnostic healthcare provider in Southern India, Vijaya Diagnostics Centre operates a network of diagnostic centers and reference laboratories serving patients across multiple cities. The company delivers comprehensive services including nuclear medicine, radiology, laboratory testing, health check-ups, and medical consultations. Its widespread infrastructure and diverse service offerings position it as a prominent player in the diagnostic healthcare sector.
Edinburgh-based global asset manager, known as abrdn until 2025 and as Standard Life Aberdeen before that. Runs active long-only Asia Pacific and India equity strategies, with a long-standing tilt toward smaller companies. Its India positions are usually built by several of its funds at the same time rather than by a single vehicle.